|
| Press Releases |
|
 |
|
| Thursday, June 19, 2025 |
|
|
ULVAC Continues Participation in "Lab-in-Fab" Project to Advance Piezoelectric MEMS Technology, Now Entering a New Phase |
| ULVAC, Inc. announced that the collaborative development project "Lab-in-Fab," aimed at advancing piezoelectric Micro-Electro-Mechanical Systems (piezoMEMS) *1 technology and in which ULVAC has participated since 2020, is entering a new phase. more info >> |
|
| Tuesday, December 6, 2022 |
|
|
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing |
| Leading pharma companies GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research (A*STAR); National University of Singapore (NUS); Nanyang Technological University, Singapore (NTU Singapore) and its innovation and enterprise company, NTUitive; and Singapore Institute of Technology (SIT) to boost Singapore's biologics manufacturing capabilities. more info >> |
|
| Thursday, June 2, 2022 |
|
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| Boehringer Ingelheim and the Agency for Science, Technology and Research (A*STAR) today announced a global licensing agreement under which Boehringer Ingelheim will obtain exclusive worldwide rights to research, develop and commercialize products based on a panel of innovative, tumor-specific antibodies from A*STAR. more info >> |
|
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| more info >> |
|
| Thursday, September 30, 2021 |
|
|
A*STAR and Local SME Work with Vaccination Centres to Deploy AVID System for Filling Syringes |
| The Agency for Science, Technology and Research (A*STAR) has developed an Automated Vaccine Inoculation Dispenser (AVID) system, which replaces the manual step of filling injection syringes with vaccine liquid. AVID is customised for the vaccination centres which are set up by the Ministry of Health and operated by private healthcare providers. more info >> |
|
| Friday, July 31, 2020 |
|
|
Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials |
| Made-in-Singapore cancer drug, ETC-159, has achieved a new developmental milestone in achieving "First Patient First Visit[1]" in Phase 1B. The first dose of ETC-159 has been administered to patients in this new phase of clinical testing, which for the first time, will look at efficacy in addition to assessing the safety of ETC-159 in treating different types of cancers. more info >> |
|
| Friday, July 24, 2020 |
|
|
MP Biomedicals and A*STAR Co-Develop Rapid Antibody Test Kit for SARS-CoV-2 |
| MP Biomedicals Asia Pacific Pte Ltd, a diagnostic corporation which has been operating for over 30 years focusing on various infectious disease testing development and manufacturing, today announced the successful development of a rapid antibody test kit for COVID-19, in collaboration with the Agency for Science, Technology and Research (A*STAR). more info >> |
|
| Tuesday, October 22, 2019 |
|
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
| Fujitsu Limited, the Singapore Management University (SMU) and the Agency for Science, Technology and Research (A*STAR)'s Institute of High Performance Computing today announced the launch of the Digital Platform Experimentation Project. more info >> |
|
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
| Fujitsu Limited, the Singapore Management University (SMU) and the Agency for Science, Technology and Research (A*STAR)'s Institute of High Performance Computing today announced the launch of the Digital Platform Experimentation Project. more info >> |
|
| Monday, October 21, 2019 |
|
|
富士通・シンガポール科学技術庁・Singapore Management University、「デジタルアニーラ」とディープラーニング技術を活用したプロジェクトを開始 |
| 富士通株式会社とシンガポール科学技術庁のハイパフォーマンスコンピューティング研究所（Institute of High Performance Computing）、およびSingapore Management Universityはこのたび、「FUJITSU Quantum-Inspired Computing Digital Annealer」とディープラーニング技術を活用したデジタルプラットフォーム実装プロジェクトを開始します。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Sinch Mailgun Report: Companies are Leaving Email Performance on the Table
Apr 26, 2026 01:00 HKT/SGT
|
|
|
Peer To Peer Network (OTC: PTOP) Targets Revenue Inflection Point with MOBICARD 1.8 Launch Expected Within 30 Days
Apr 25, 2026 07:03 HKT/SGT
|
|
|
EQIBank expands global, regulated Banking-as-a-Service platform for cross-border banking across fiat and digital assets
Apr 24, 2026 20:00: JST
|
|
|
EQIBank expands global, regulated Banking-as-a-Service platform for cross-border banking across fiat and digital assets
Apr 24, 2026 19:00 HKT/SGT
|
|
|
FastX Announces Its Launch, a New Generation Global Trading Exchange
Apr 24, 2026 13:00: JST
|
|
|
analytica Hanoi 2026 Makes Its Debut, Bringing the Global Science and Laboratory Platform to Northern Vietnam
Apr 24, 2026 12:05 HKT/SGT
|
|
|
FastX Announces Its Launch, a New Generation Global Trading Exchange
Apr 24, 2026 12:00 HKT/SGT
|
|
|
CMS (867.HK; 8A8.SG): NDA for the Seasonal Allergic Rhinitis Indication of Class 1 Innovative Drug MG-K10 Accepted in China
Apr 23, 2026 23:00: JST
|
|
|
CMS (867.HK; 8A8.SG): NDA for the Seasonal Allergic Rhinitis Indication of Class 1 Innovative Drug MG-K10 Accepted in China
Apr 23, 2026 22:00 HKT/SGT
|
|
|
Smart Lighting Expo and Lighting Fair conclude successfully
Apr 23, 2026 20:33: JST
|
|
|
Sisel International Appoints Pamela Ferry as General Manager of Australia and New Zealand to Support Regional Expansion
Apr 23, 2026 20:00: JST
|
|
|
康哲藥業：1類新藥MG-K10季節性過敏性鼻炎適應症NDA獲受理
Apr 23, 2026 19:48 HKT/SGT
|
|
|
康哲药业：1类新药MG-K10季节性过敏性鼻炎适应症NDA获受理
Apr 23, 2026 19:48 HKT/SGT
|
|
|
Smart Lighting Expo and Lighting Fair conclude successfully
Apr 23, 2026 19:33 HKT/SGT
|
|
|
GA Ventures Ltd 宣布正式推出 FastX：新一代全球交易交易所
Apr 23, 2026 19:12 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
